For exploring therapeutic potential of compound 8a as a drug used to treat allergic asthma, in this study, we assessed effective and specific activity of compound 8a targeting the interaction of CCR4 and their ligands and its toxicity in vitro. Further, we demonstrated in vivo effectiveness of compound 8a in a murine model of allergic asthma. The gene discussed is CCR4; the disease is allergic asthma.